Avner Lushi founded Guangzhou Sino-Israel Biotech Investment Fund and Life Sciences Transaction Support Ltd. Presently, he is Chief Executive Officer & Managing Partner at Guangzhou Sino-Israel Biotech Investment Fund. Mr. Lushi is also on the board of 11 other companies.
In the past Mr. Lushi held the position of Chief Executive Officer of Monaliza Medical Ltd., Chief Executive Officer for Life Sciences Transaction Support Ltd. and Managing Director at I.H.C.V Israel Healthcare Ventures Ltd.
Avner Lushi received an undergraduate degree and a graduate degree from the University of Haifa and a graduate degree from The Hebrew University of Jerusalem.